Homeobox B9: A potential surrogate marker for bevacizumab in combination with chemotherapy in colorectal cancer

Yoshinori Hoshino; Tetsu Hayashida; Akira Hirata; Koji Okabayashi; Hiroki Ochiai; Takashi Endo; Yoshiyuki Ishii; Hiromitsu Jinno; Hirotoshi Hasegawa; Yuko Kitagawa

Homeobox B9: A potential surrogate marker for bevacizumab in combination with chemotherapy in colorectal cancer

Yoshinori Hoshino
, Tetsu Hayashida
, Akira Hirata
, Koji Okabayashi
, Hiroki Ochiai
, Takashi Endo
, Yoshiyuki Ishii
, Hiromitsu Jinno
, Hirotoshi Hasegawa
, Yuko Kitagawa

School of Medicine

Research output: Contribution to journal › Article

Original language	English
Journal	JOURNAL OF CLINICAL ONCOLOGY
Volume	30
Issue number	15
State	Published - May 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{6fb2880a93d6465781511a700ac1022d,

title = "Homeobox B9: A potential surrogate marker for bevacizumab in combination with chemotherapy in colorectal cancer",

author = "Yoshinori Hoshino and Tetsu Hayashida and Akira Hirata and Koji Okabayashi and Hiroki Ochiai and Takashi Endo and Yoshiyuki Ishii and Hiromitsu Jinno and Hirotoshi Hasegawa and Yuko Kitagawa",

year = "2012",

month = may,

language = "英語",

volume = "30",

journal = "JOURNAL OF CLINICAL ONCOLOGY",

issn = "0732-183X",

number = "15",

}

TY - JOUR

T1 - Homeobox B9: A potential surrogate marker for bevacizumab in combination with chemotherapy in colorectal cancer

AU - Hoshino, Yoshinori

AU - Hayashida, Tetsu

AU - Hirata, Akira

AU - Okabayashi, Koji

AU - Ochiai, Hiroki

AU - Endo, Takashi

AU - Ishii, Yoshiyuki

AU - Jinno, Hiromitsu

AU - Hasegawa, Hirotoshi

AU - Kitagawa, Yuko

PY - 2012/5

Y1 - 2012/5

M3 - 記事

SN - 0732-183X

VL - 30

JO - JOURNAL OF CLINICAL ONCOLOGY

JF - JOURNAL OF CLINICAL ONCOLOGY

IS - 15

ER -